NCT01720563 2025-06-04A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent ChemoradiotherapyPhytoHealth CorporationPhase 2 Terminated17 enrolled